The global FPR1 Inhibitor market was valued at US$ 86.3 million in 2023 and is anticipated to reach US$ 122 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.

FPR1 Inhibitor Market

FPR1 inhibitor is a compound or substance used to inhibit the activity of FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that is involved in regulating biological processes such as inflammation, immunity, and cell migration. FPR1 inhibitors bind to FPR1 and block its signaling pathway, thereby inhibiting its related biological responses. These inhibitors are often used in scientific research to explore the role of FPR1 in physiological and pathological processes and may serve as potential drug targets for the development of disease treatments.

The FPR1 inhibitor market has shown a steady development trend in recent years. With in-depth research on the biological functions of FPR1 (Formyl Peptide Receptor 1), its key role in inflammatory response, cell migration, cancer development and other processes has been gradually revealed, which has promoted the development and application of FPR1 inhibitors. FPR1 inhibitors are mainly used in scientific research experiments, especially in drug discovery and mechanism research, playing an important role. They provide researchers with tools to regulate FPR1 function to gain insights into related physiological processes and develop novel treatments. In summary, the FPR1 inhibitor market has broad development prospects and huge market potential.

Report Scope

This report aims to provide a comprehensive presentation of the global market for FPR1 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding FPR1 Inhibitor.

The FPR1 Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global FPR1 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the FPR1 Inhibitor manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of FPR1 Inhibitor Market Report

Report Metric	Details
Report Name	FPR1 Inhibitor Market
Accounted market size in 2023	US$ 86.3 million
Forecasted market size in 2030	US$ 122 million
CAGR	5.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Protein Inhibitors RNA or DNA Inhibitors
Segment by Application	Biomedicine Drug Discovery Clinical Diagnosis
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	MedChemExpress (MCE), Merck, Cayman Chemical, Santa Cruz Biotechnology, R&D Systems, Abcam, Selleck Chemicals, Tocris Bioscience, ApexBio Technology, ChemBridge Corporation, APPTEC, Liding Biotechnology, Zhiyuan Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of FPR1 Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of FPR1 Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is FPR1 Inhibitor Market growing?

Ans: The FPR1 Inhibitor Market witnessing a CAGR of 5.0% during the forecast period 2024-2030.

What is the FPR1 Inhibitor Market size in 2030?

Ans: The FPR1 Inhibitor Market size in 2030 will be US$ 122 million.

Who are the main players in the FPR1 Inhibitor Market report?

Ans: The main players in the FPR1 Inhibitor Market are MedChemExpress (MCE), Merck, Cayman Chemical, Santa Cruz Biotechnology, R&D Systems, Abcam, Selleck Chemicals, Tocris Bioscience, ApexBio Technology, ChemBridge Corporation, APPTEC, Liding Biotechnology, Zhiyuan Biotechnology

What are the Application segmentation covered in the FPR1 Inhibitor Market report?

Ans: The Applications covered in the FPR1 Inhibitor Market report are Biomedicine, Drug Discovery, Clinical Diagnosis

What are the Type segmentation covered in the FPR1 Inhibitor Market report?

Ans: The Types covered in the FPR1 Inhibitor Market report are Protein Inhibitors, RNA or DNA Inhibitors

1 FPR1 Inhibitor Market Overview

1.1 Product Definition

1.2 FPR1 Inhibitor by Type

1.2.1 Global FPR1 Inhibitor Market Value Comparison by Type (2024-2030)

1.2.2 Protein Inhibitors

1.2.3 RNA or DNA Inhibitors

1.3 FPR1 Inhibitor by Application

1.3.1 Global FPR1 Inhibitor Market Value by Application (2024-2030)

1.3.2 Biomedicine

1.3.3 Drug Discovery

1.3.4 Clinical Diagnosis

1.4 Global FPR1 Inhibitor Market Size Estimates and Forecasts

1.4.1 Global FPR1 Inhibitor Revenue 2019-2030

1.4.2 Global FPR1 Inhibitor Sales 2019-2030

1.4.3 Global FPR1 Inhibitor Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 FPR1 Inhibitor Market Competition by Manufacturers

2.1 Global FPR1 Inhibitor Sales Market Share by Manufacturers (2019-2024)

2.2 Global FPR1 Inhibitor Revenue Market Share by Manufacturers (2019-2024)

2.3 Global FPR1 Inhibitor Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of FPR1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of FPR1 Inhibitor, Product Type & Application

2.7 Global Key Manufacturers of FPR1 Inhibitor, Date of Enter into This Industry

2.8 Global FPR1 Inhibitor Market Competitive Situation and Trends

2.8.1 Global FPR1 Inhibitor Market Concentration Rate

2.8.2 The Global 5 and 10 Largest FPR1 Inhibitor Players Market Share by Revenue

2.8.3 Global FPR1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global FPR1 Inhibitor Market Scenario by Region

3.1 Global FPR1 Inhibitor Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global FPR1 Inhibitor Sales by Region: 2019-2030

3.2.1 Global FPR1 Inhibitor Sales by Region: 2019-2024

3.2.2 Global FPR1 Inhibitor Sales by Region: 2025-2030

3.3 Global FPR1 Inhibitor Revenue by Region: 2019-2030

3.3.1 Global FPR1 Inhibitor Revenue by Region: 2019-2024

3.3.2 Global FPR1 Inhibitor Revenue by Region: 2025-2030

3.4 North America FPR1 Inhibitor Market Facts & Figures by Country

3.4.1 North America FPR1 Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America FPR1 Inhibitor Sales by Country (2019-2030)

3.4.3 North America FPR1 Inhibitor Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe FPR1 Inhibitor Market Facts & Figures by Country

3.5.1 Europe FPR1 Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe FPR1 Inhibitor Sales by Country (2019-2030)

3.5.3 Europe FPR1 Inhibitor Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific FPR1 Inhibitor Market Facts & Figures by Region

3.6.1 Asia Pacific FPR1 Inhibitor Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific FPR1 Inhibitor Sales by Region (2019-2030)

3.6.3 Asia Pacific FPR1 Inhibitor Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America FPR1 Inhibitor Market Facts & Figures by Country

3.7.1 Latin America FPR1 Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America FPR1 Inhibitor Sales by Country (2019-2030)

3.7.3 Latin America FPR1 Inhibitor Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa FPR1 Inhibitor Market Facts & Figures by Country

3.8.1 Middle East and Africa FPR1 Inhibitor Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa FPR1 Inhibitor Sales by Country (2019-2030)

3.8.3 Middle East and Africa FPR1 Inhibitor Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global FPR1 Inhibitor Sales by Type (2019-2030)

4.1.1 Global FPR1 Inhibitor Sales by Type (2019-2024)

4.1.2 Global FPR1 Inhibitor Sales by Type (2025-2030)

4.1.3 Global FPR1 Inhibitor Sales Market Share by Type (2019-2030)

4.2 Global FPR1 Inhibitor Revenue by Type (2019-2030)

4.2.1 Global FPR1 Inhibitor Revenue by Type (2019-2024)

4.2.2 Global FPR1 Inhibitor Revenue by Type (2025-2030)

4.2.3 Global FPR1 Inhibitor Revenue Market Share by Type (2019-2030)

4.3 Global FPR1 Inhibitor Price by Type (2019-2030)

5 Segment by Application

5.1 Global FPR1 Inhibitor Sales by Application (2019-2030)

5.1.1 Global FPR1 Inhibitor Sales by Application (2019-2024)

5.1.2 Global FPR1 Inhibitor Sales by Application (2025-2030)

5.1.3 Global FPR1 Inhibitor Sales Market Share by Application (2019-2030)

5.2 Global FPR1 Inhibitor Revenue by Application (2019-2030)

5.2.1 Global FPR1 Inhibitor Revenue by Application (2019-2024)

5.2.2 Global FPR1 Inhibitor Revenue by Application (2025-2030)

5.2.3 Global FPR1 Inhibitor Revenue Market Share by Application (2019-2030)

5.3 Global FPR1 Inhibitor Price by Application (2019-2030)

6 Key Companies Profiled

6.1 MedChemExpress (MCE)

6.1.1 MedChemExpress (MCE) Company Information

6.1.2 MedChemExpress (MCE) Description and Business Overview

6.1.3 MedChemExpress (MCE) FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.1.4 MedChemExpress (MCE) FPR1 Inhibitor Product Portfolio

6.1.5 MedChemExpress (MCE) Recent Developments/Updates

6.2 Merck

6.2.1 Merck Company Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck FPR1 Inhibitor Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Cayman Chemical

6.3.1 Cayman Chemical Company Information

6.3.2 Cayman Chemical Description and Business Overview

6.3.3 Cayman Chemical FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Cayman Chemical FPR1 Inhibitor Product Portfolio

6.3.5 Cayman Chemical Recent Developments/Updates

6.4 Santa Cruz Biotechnology

6.4.1 Santa Cruz Biotechnology Company Information

6.4.2 Santa Cruz Biotechnology Description and Business Overview

6.4.3 Santa Cruz Biotechnology FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Santa Cruz Biotechnology FPR1 Inhibitor Product Portfolio

6.4.5 Santa Cruz Biotechnology Recent Developments/Updates

6.5 R&D Systems

6.5.1 R&D Systems Company Information

6.5.2 R&D Systems Description and Business Overview

6.5.3 R&D Systems FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.5.4 R&D Systems FPR1 Inhibitor Product Portfolio

6.5.5 R&D Systems Recent Developments/Updates

6.6 Abcam

6.6.1 Abcam Company Information

6.6.2 Abcam Description and Business Overview

6.6.3 Abcam FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Abcam FPR1 Inhibitor Product Portfolio

6.6.5 Abcam Recent Developments/Updates

6.7 Selleck Chemicals

6.7.1 Selleck Chemicals Company Information

6.7.2 Selleck Chemicals Description and Business Overview

6.7.3 Selleck Chemicals FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Selleck Chemicals FPR1 Inhibitor Product Portfolio

6.7.5 Selleck Chemicals Recent Developments/Updates

6.8 Tocris Bioscience

6.8.1 Tocris Bioscience Company Information

6.8.2 Tocris Bioscience Description and Business Overview

6.8.3 Tocris Bioscience FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Tocris Bioscience FPR1 Inhibitor Product Portfolio

6.8.5 Tocris Bioscience Recent Developments/Updates

6.9 ApexBio Technology

6.9.1 ApexBio Technology Company Information

6.9.2 ApexBio Technology Description and Business Overview

6.9.3 ApexBio Technology FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.9.4 ApexBio Technology FPR1 Inhibitor Product Portfolio

6.9.5 ApexBio Technology Recent Developments/Updates

6.10 ChemBridge Corporation

6.10.1 ChemBridge Corporation Company Information

6.10.2 ChemBridge Corporation Description and Business Overview

6.10.3 ChemBridge Corporation FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.10.4 ChemBridge Corporation FPR1 Inhibitor Product Portfolio

6.10.5 ChemBridge Corporation Recent Developments/Updates

6.11 APPTEC

6.11.1 APPTEC Company Information

6.11.2 APPTEC Description and Business Overview

6.11.3 APPTEC FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.11.4 APPTEC FPR1 Inhibitor Product Portfolio

6.11.5 APPTEC Recent Developments/Updates

6.12 Liding Biotechnology

6.12.1 Liding Biotechnology Company Information

6.12.2 Liding Biotechnology Description and Business Overview

6.12.3 Liding Biotechnology FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Liding Biotechnology FPR1 Inhibitor Product Portfolio

6.12.5 Liding Biotechnology Recent Developments/Updates

6.13 Zhiyuan Biotechnology

6.13.1 Zhiyuan Biotechnology Company Information

6.13.2 Zhiyuan Biotechnology Description and Business Overview

6.13.3 Zhiyuan Biotechnology FPR1 Inhibitor Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Zhiyuan Biotechnology FPR1 Inhibitor Product Portfolio

6.13.5 Zhiyuan Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 FPR1 Inhibitor Industry Chain Analysis

7.2 FPR1 Inhibitor Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 FPR1 Inhibitor Production Mode & Process

7.4 FPR1 Inhibitor Sales and Marketing

7.4.1 FPR1 Inhibitor Sales Channels

7.4.2 FPR1 Inhibitor Distributors

7.5 FPR1 Inhibitor Customers

8 FPR1 Inhibitor Market Dynamics

8.1 FPR1 Inhibitor Industry Trends

8.2 FPR1 Inhibitor Market Drivers

8.3 FPR1 Inhibitor Market Challenges

8.4 FPR1 Inhibitor Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

MedChemExpress (MCE)

Merck

Cayman Chemical

Santa Cruz Biotechnology

Zhiyuan Biotechnology

ChemBridge Corporation

List of Tables

Table 1. Global FPR1 Inhibitor Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global FPR1 Inhibitor Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global FPR1 Inhibitor Market Competitive Situation by Manufacturers in 2023

Table 4. Global FPR1 Inhibitor Sales (K Dose) of Key Manufacturers (2019-2024)

Table 5. Global FPR1 Inhibitor Sales Market Share by Manufacturers (2019-2024)

Table 6. Global FPR1 Inhibitor Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global FPR1 Inhibitor Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market FPR1 Inhibitor Average Price (US$/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of FPR1 Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of FPR1 Inhibitor, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of FPR1 Inhibitor, Product Type & Application

Table 12. Global Key Manufacturers of FPR1 Inhibitor, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global FPR1 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FPR1 Inhibitor as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global FPR1 Inhibitor Sales by Region (2019-2024) & (K Dose)

Table 18. Global FPR1 Inhibitor Sales Market Share by Region (2019-2024)

Table 19. Global FPR1 Inhibitor Sales by Region (2025-2030) & (K Dose)

Table 20. Global FPR1 Inhibitor Sales Market Share by Region (2025-2030)

Table 21. Global FPR1 Inhibitor Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global FPR1 Inhibitor Revenue Market Share by Region (2019-2024)

Table 23. Global FPR1 Inhibitor Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global FPR1 Inhibitor Revenue Market Share by Region (2025-2030)

Table 25. North America FPR1 Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America FPR1 Inhibitor Sales by Country (2019-2024) & (K Dose)

Table 27. North America FPR1 Inhibitor Sales by Country (2025-2030) & (K Dose)

Table 28. North America FPR1 Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America FPR1 Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe FPR1 Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe FPR1 Inhibitor Sales by Country (2019-2024) & (K Dose)

Table 32. Europe FPR1 Inhibitor Sales by Country (2025-2030) & (K Dose)

Table 33. Europe FPR1 Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe FPR1 Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific FPR1 Inhibitor Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific FPR1 Inhibitor Sales by Region (2019-2024) & (K Dose)

Table 37. Asia Pacific FPR1 Inhibitor Sales by Region (2025-2030) & (K Dose)

Table 38. Asia Pacific FPR1 Inhibitor Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific FPR1 Inhibitor Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America FPR1 Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America FPR1 Inhibitor Sales by Country (2019-2024) & (K Dose)

Table 42. Latin America FPR1 Inhibitor Sales by Country (2025-2030) & (K Dose)

Table 43. Latin America FPR1 Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America FPR1 Inhibitor Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa FPR1 Inhibitor Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa FPR1 Inhibitor Sales by Country (2019-2024) & (K Dose)

Table 47. Middle East and Africa FPR1 Inhibitor Sales by Country (2025-2030) & (K Dose)

Table 48. Middle East and Africa FPR1 Inhibitor Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa FPR1 Inhibitor Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global FPR1 Inhibitor Sales (K Dose) by Type (2019-2024)

Table 51. Global FPR1 Inhibitor Sales (K Dose) by Type (2025-2030)

Table 52. Global FPR1 Inhibitor Sales Market Share by Type (2019-2024)

Table 53. Global FPR1 Inhibitor Sales Market Share by Type (2025-2030)

Table 54. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2019-2024)

Table 55. Global FPR1 Inhibitor Revenue (US$ Million) by Type (2025-2030)

Table 56. Global FPR1 Inhibitor Revenue Market Share by Type (2019-2024)

Table 57. Global FPR1 Inhibitor Revenue Market Share by Type (2025-2030)

Table 58. Global FPR1 Inhibitor Price (US$/Dose) by Type (2019-2024)

Table 59. Global FPR1 Inhibitor Price (US$/Dose) by Type (2025-2030)

Table 60. Global FPR1 Inhibitor Sales (K Dose) by Application (2019-2024)

Table 61. Global FPR1 Inhibitor Sales (K Dose) by Application (2025-2030)

Table 62. Global FPR1 Inhibitor Sales Market Share by Application (2019-2024)

Table 63. Global FPR1 Inhibitor Sales Market Share by Application (2025-2030)

Table 64. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2019-2024)

Table 65. Global FPR1 Inhibitor Revenue (US$ Million) by Application (2025-2030)

Table 66. Global FPR1 Inhibitor Revenue Market Share by Application (2019-2024)

Table 67. Global FPR1 Inhibitor Revenue Market Share by Application (2025-2030)

Table 68. Global FPR1 Inhibitor Price (US$/Dose) by Application (2019-2024)

Table 69. Global FPR1 Inhibitor Price (US$/Dose) by Application (2025-2030)

Table 70. MedChemExpress (MCE) Company Information

Table 71. MedChemExpress (MCE) Description and Business Overview

Table 72. MedChemExpress (MCE) FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 73. MedChemExpress (MCE) FPR1 Inhibitor Product

Table 74. MedChemExpress (MCE) Recent Developments/Updates

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 78. Merck FPR1 Inhibitor Product

Table 79. Merck Recent Developments/Updates

Table 80. Cayman Chemical Company Information

Table 81. Cayman Chemical Description and Business Overview

Table 82. Cayman Chemical FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 83. Cayman Chemical FPR1 Inhibitor Product

Table 84. Cayman Chemical Recent Developments/Updates

Table 85. Santa Cruz Biotechnology Company Information

Table 86. Santa Cruz Biotechnology Description and Business Overview

Table 87. Santa Cruz Biotechnology FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 88. Santa Cruz Biotechnology FPR1 Inhibitor Product

Table 89. Santa Cruz Biotechnology Recent Developments/Updates

Table 90. R&D Systems Company Information

Table 91. R&D Systems Description and Business Overview

Table 92. R&D Systems FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 93. R&D Systems FPR1 Inhibitor Product

Table 94. R&D Systems Recent Developments/Updates

Table 95. Abcam Company Information

Table 96. Abcam Description and Business Overview

Table 97. Abcam FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 98. Abcam FPR1 Inhibitor Product

Table 99. Abcam Recent Developments/Updates

Table 100. Selleck Chemicals Company Information

Table 101. Selleck Chemicals Description and Business Overview

Table 102. Selleck Chemicals FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 103. Selleck Chemicals FPR1 Inhibitor Product

Table 104. Selleck Chemicals Recent Developments/Updates

Table 105. Tocris Bioscience Company Information

Table 106. Tocris Bioscience Description and Business Overview

Table 107. Tocris Bioscience FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 108. Tocris Bioscience FPR1 Inhibitor Product

Table 109. Tocris Bioscience Recent Developments/Updates

Table 110. ApexBio Technology Company Information

Table 111. ApexBio Technology Description and Business Overview

Table 112. ApexBio Technology FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 113. ApexBio Technology FPR1 Inhibitor Product

Table 114. ApexBio Technology Recent Developments/Updates

Table 115. ChemBridge Corporation Company Information

Table 116. ChemBridge Corporation Description and Business Overview

Table 117. ChemBridge Corporation FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 118. ChemBridge Corporation FPR1 Inhibitor Product

Table 119. ChemBridge Corporation Recent Developments/Updates

Table 120. APPTEC Company Information

Table 121. APPTEC Description and Business Overview

Table 122. APPTEC FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 123. APPTEC FPR1 Inhibitor Product

Table 124. APPTEC Recent Developments/Updates

Table 125. Liding Biotechnology Company Information

Table 126. Liding Biotechnology Description and Business Overview

Table 127. Liding Biotechnology FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 128. Liding Biotechnology FPR1 Inhibitor Product

Table 129. Liding Biotechnology Recent Developments/Updates

Table 130. Zhiyuan Biotechnology Company Information

Table 131. Zhiyuan Biotechnology Description and Business Overview

Table 132. Zhiyuan Biotechnology FPR1 Inhibitor Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 133. Zhiyuan Biotechnology FPR1 Inhibitor Product

Table 134. Zhiyuan Biotechnology Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. FPR1 Inhibitor Distributors List

Table 138. FPR1 Inhibitor Customers List

Table 139. FPR1 Inhibitor Market Trends

Table 140. FPR1 Inhibitor Market Drivers

Table 141. FPR1 Inhibitor Market Challenges

Table 142. FPR1 Inhibitor Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of FPR1 Inhibitor

Figure 2. Global FPR1 Inhibitor Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global FPR1 Inhibitor Market Share by Type: 2023 & 2030

Figure 4. Protein Inhibitors Product Picture

Figure 5. RNA or DNA Inhibitors Product Picture

Figure 6. Global FPR1 Inhibitor Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global FPR1 Inhibitor Market Share by Application: 2023 & 2030

Figure 8. Biomedicine

Figure 9. Drug Discovery

Figure 10. Clinical Diagnosis

Figure 11. Global FPR1 Inhibitor Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global FPR1 Inhibitor Market Size (2019-2030) & (US$ Million)

Figure 13. Global FPR1 Inhibitor Sales (2019-2030) & (K Dose)

Figure 14. Global FPR1 Inhibitor Average Price (US$/Dose) & (2019-2030)

Figure 15. FPR1 Inhibitor Report Years Considered

Figure 16. FPR1 Inhibitor Sales Share by Manufacturers in 2023

Figure 17. Global FPR1 Inhibitor Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest FPR1 Inhibitor Players: Market Share by Revenue in FPR1 Inhibitor in 2023

Figure 19. FPR1 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global FPR1 Inhibitor Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America FPR1 Inhibitor Sales Market Share by Country (2019-2030)

Figure 22. North America FPR1 Inhibitor Revenue Market Share by Country (2019-2030)

Figure 23. United States FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe FPR1 Inhibitor Sales Market Share by Country (2019-2030)

Figure 26. Europe FPR1 Inhibitor Revenue Market Share by Country (2019-2030)

Figure 27. Germany FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific FPR1 Inhibitor Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific FPR1 Inhibitor Revenue Market Share by Region (2019-2030)

Figure 34. China FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America FPR1 Inhibitor Sales Market Share by Country (2019-2030)

Figure 42. Mexico FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa FPR1 Inhibitor Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa FPR1 Inhibitor Revenue Market Share by Country (2019-2030)

Figure 48. Turkey FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE FPR1 Inhibitor Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of FPR1 Inhibitor by Type (2019-2030)

Figure 52. Global Revenue Market Share of FPR1 Inhibitor by Type (2019-2030)

Figure 53. Global FPR1 Inhibitor Price (US$/Dose) by Type (2019-2030)

Figure 54. Global Sales Market Share of FPR1 Inhibitor by Application (2019-2030)

Figure 55. Global Revenue Market Share of FPR1 Inhibitor by Application (2019-2030)

Figure 56. Global FPR1 Inhibitor Price (US$/Dose) by Application (2019-2030)

Figure 57. FPR1 Inhibitor Value Chain

Figure 58. FPR1 Inhibitor Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions